Published in SUNS #6911 dated 26 April 2010
Geneva, 23 Apr (Kanaga Raja) -- The United States has been using trade agreements, foreign aid, technical assistance and diplomatic pressure to promote intellectual property and pharmaceutical regulations that restrict access to affordable medicines in developing countries, health advocacy organizations have said.
In a submission to the United Nations Human Rights Council this week, the health advocacy groups said that the US move is coming at the expense of human rights.